Joseph Manetta

1.7k total citations
19 papers, 1.5k citations indexed

About

Joseph Manetta is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Joseph Manetta has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Immunology and 3 papers in Infectious Diseases. Recurrent topics in Joseph Manetta's work include Protein Kinase Regulation and GTPase Signaling (5 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Joseph Manetta is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (5 papers), HIV/AIDS drug development and treatment (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Joseph Manetta collaborates with scholars based in United States. Joseph Manetta's co-authors include Ruth M. Kramer, Lawrence J. Slieker, Aidas Kriauciunas, Thomas W. Stephens, Kyle W. Sloop, Peggy L. Surface, Paul A. Hyslop, Joseph A. Jakubowski, John Sharp and Derrick R. Witcher and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Diabetes.

In The Last Decade

Joseph Manetta

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Manetta United States 13 668 384 375 299 239 19 1.5k
Wataru Motomura Japan 19 905 1.4× 292 0.8× 293 0.8× 148 0.5× 365 1.5× 27 1.8k
Satoshi Tsuzuki Japan 22 928 1.4× 211 0.5× 165 0.4× 428 1.4× 34 0.1× 83 2.1k
Takahide Ohishi Japan 19 1.2k 1.8× 112 0.3× 371 1.0× 94 0.3× 154 0.6× 25 2.2k
Ximena Opitz-Araya United States 8 1.4k 2.2× 274 0.7× 86 0.2× 306 1.0× 199 0.8× 8 2.0k
Man‐Wook Hur South Korea 26 1.4k 2.1× 74 0.2× 269 0.7× 59 0.2× 131 0.5× 77 2.0k
Nunzia Pastore Italy 15 513 0.8× 91 0.2× 216 0.6× 169 0.6× 371 1.6× 24 1.2k
Laura R. Pearce United Kingdom 8 1.6k 2.5× 98 0.3× 190 0.5× 58 0.2× 146 0.6× 9 2.1k
Martha H. Corjay United States 18 1.1k 1.6× 90 0.2× 126 0.3× 56 0.2× 159 0.7× 24 2.0k
Nadine Huber Finland 18 658 1.0× 102 0.3× 235 0.6× 54 0.2× 229 1.0× 32 1.3k
Kay Barnes United Kingdom 25 1.0k 1.5× 70 0.2× 602 1.6× 42 0.1× 136 0.6× 36 2.0k

Countries citing papers authored by Joseph Manetta

Since Specialization
Citations

This map shows the geographic impact of Joseph Manetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Manetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Manetta more than expected).

Fields of papers citing papers by Joseph Manetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Manetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Manetta. The network helps show where Joseph Manetta may publish in the future.

Co-authorship network of co-authors of Joseph Manetta

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Manetta. A scholar is included among the top collaborators of Joseph Manetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Manetta. Joseph Manetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Benschop, Robert J., Chi-Kin Chow, Yu Tian, et al.. (2019). Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. mAbs. 11(6). 1175–1190. 34 indexed citations
2.
Lee, Richard H., et al.. (2017). Maternal Serum B-Cell Activating Factor Levels. Hypertension. 70(5). 1007–1013. 9 indexed citations
3.
Kikly, Kristine, Joseph Manetta, Holly A. Bina, et al.. (2014). Generation and characterization of tabalumab, a human monoclonal antibody that neutralizes both soluble and membrane-bound B-cell activating factor. Journal of Inflammation Research. 7. 121–121. 39 indexed citations
5.
Butterfield, Anthony, Peng Luan, Derrick R. Witcher, et al.. (2010). A Dual-Monoclonal Sandwich ELISA Specific for Hepcidin-25. Clinical Chemistry. 56(11). 1725–1732. 51 indexed citations
6.
Wroblewski, Victor J., et al.. (2003). Pharmacokinetics, Metabolic Stability, and Subcutaneous Bioavailability of a Genetically Engineered Analog of DcR3, FLINT [DcR3(R218Q)], in Cynomolgus Monkeys and Mice. Drug Metabolism and Disposition. 31(4). 502–507. 10 indexed citations
7.
Myers, Sharon L., W. Thomas Johnson, James E. Baker, et al.. (1997). Acylation of Human Insulin With Palmitic Acid Extends the Time Action of Human Insulin in Diabetic Dogs. Diabetes. 46(4). 637–642. 55 indexed citations
8.
Kahl, Steven D., et al.. (1996). A Multiple-Approach Scintillation Proximity Assay to Measure the Association between Ras and Raf. Analytical Biochemistry. 243(2). 282–283. 4 indexed citations
9.
Slieker, Lawrence J., Kyle W. Sloop, Peggy L. Surface, et al.. (1996). Regulation of Expression of ob mRNA and Protein by Glucocorticoids and cAMP. Journal of Biological Chemistry. 271(10). 5301–5304. 425 indexed citations
10.
Stephenson, Diane, Joseph Manetta, D. L. White, et al.. (1994). Calcium-sensitive cytosolic phospholipase A2 (cPLA2) is expressed in human brain astrocytes. Brain Research. 637(1-2). 97–105. 76 indexed citations
11.
Sharp, John, Richard T. Pickard, X. Grace Chiou, et al.. (1994). Serine 228 is essential for catalytic activities of 85-kDa cytosolic phospholipase A2.. Journal of Biological Chemistry. 269(37). 23250–23254. 103 indexed citations
12.
Kramer, Ruth M., et al.. (1993). Ca(2+)-sensitive cytosolic phospholipase A2 (cPLA2) in human platelets.. PubMed. 6(1-3). 209–16. 8 indexed citations
13.
Kramer, Ruth M., et al.. (1993). Thrombin-induced phosphorylation and activation of Ca(2+)-sensitive cytosolic phospholipase A2 in human platelets.. Journal of Biological Chemistry. 268(35). 26796–26804. 166 indexed citations
14.
Hui, Kwan Y., et al.. (1993). Model peptides to study the effects of P2 and P3 substitutions in statine‐containing HIV proteinase inhibitors. FEBS Letters. 327(3). 355–360. 8 indexed citations
15.
Manetta, Joseph, Mei‐Huei T. Lai, Harold E. Osborne, et al.. (1992). Design and implementation of a particle concentration fluorescence method for the detection of HIV-1 protease inhibitors. Analytical Biochemistry. 202(1). 10–15. 13 indexed citations
16.
Slieker, Lawrence J., et al.. (1992). Glucose Transporter Levels in Tissues of Spontaneously Diabetic Zucker fa/fa Rat (ZDF/drt) and Viable Yellow Mouse (Avy/a). Diabetes. 41(2). 187–193. 71 indexed citations
17.
Kramer, Ruth M., et al.. (1991). The Ca2(+)-sensitive cytosolic phospholipase A2 is a 100-kDa protein in human monoblast U937 cells.. Journal of Biological Chemistry. 266(8). 5268–5272. 366 indexed citations
18.
Hui, Kwan Y., Joseph Manetta, Bonnie J. Bowdon, et al.. (1991). A rational approach in the search for potent inhibitors against HIV proteinase. The FASEB Journal. 5(11). 2606–2610. 13 indexed citations
19.
Butler, L D, Cathy Browne, Jingyi Tang, et al.. (1988). In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency states.. PubMed. 48(21). 6081–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026